Could Pradaxa Litigation be the Cause of a Drop in Manufacturer Sales?
Boehringer Ingelheim, the German manufacturer of Pradaxa, has seen a five-percent loss in sales over the first half of 2014. During that time the company encountered a number […]
U.S. Set Record Drug Recalls in 2014
The Regulatory Affairs Professionals Society has released a report in which the organization estimates that the number of drug recalls in 2014 may be the highest in history. The U.S. […]
Lawsuits Filed Over Alleged Xarelto Issues
Last week, a Florida plaintiff brought a Xarelto lawsuit alleging certain Xarelto issues in federal court. The plaintiff seeks damages sustained by her and her deceased husband who […]
Adverse Event Reports from Xarelto Patients
Xarelto, an anticoagulant used in the treatment and prevention of deep vein thrombosis, is a prescription-only drug in tablet form. The generic form of the medication is Revaroxaban. […]
Boehringer Ingelheim Announces $650M Pradaxa Settlement
Boehringer Ingelheim announced on May 28, 2014 an agreement to settle litigation involving their prescription blood thinner Pradaxa (dabigatran). The company estimates that the Pradaxa settlement of $650 […]
Problems with Pradaxa Becoming Widely Discussed
Pradaxa and Xarelto are promoted for their effectiveness, safety, and ease of use for both the physician and the patient, but these new oral anticoagulants have one drawback […]
Call us today for your free case review(888) 888-0612
Xarelto Lawsuit Lawyers Want Patients to be Aware of the Reported Risks of Xarelto
Xarelto, or rivaroxaban, is a blood-thinning medication manufactured and marketed by Bayer Healthcare and Johnson & Johnson. The drug was approved by the U.S. Food and Drug Administration […]